Technologies
Qualigen Therapeutics Inc (QLGN) Has Great Growth Outlook For 2025
Qualigen Therapeutics Inc (NASDAQ:QLGN) has a beta value of -0.16 and has seen 40.81 million shares traded in the recent trading session. The company, currently
Qualigen Therapeutics Inc (NASDAQ:QLGN) has a beta value of -0.16 and has seen 40.81 million shares traded in the recent trading session. The company, currently
© 2024, Powered by Smart TechOne